Oxidative-antioxidative status of blood plasma in bitches with mammary gland tumours

• Autorzy: Szczubial M , Kankofer M. , Albera E. , Lopuszynski W. , Dabrowski R.
• Języki publikacji: EN

Abstrakty

EN

The aim of the study was the estimation of oxidative/antioxidative status of bitches with mammary gland tumours by the determination of lipid peroxidation intensity, concentration of glutathione and β-carotene as well as total antioxidant capacity (TAC) in blood plasma. The experiment was carried out on 18 bitches with spontaneously occurring mammary gland tumours (12 with malignant tumours and 6 with benign tumours) and 6 clinically healthy controls. The intensity of lipid peroxidation did not differ significantly among the examined groups of animals. The concentration of glutathione was higher in both neoplasm groups than in healthy bitches, but the differences were not significant. The concentration of β-carotene in plasma was similar in cases of malignant and benign tumours, but was significantly lower (P<0.05) than in healthy controls. TAC of plasma was lower in bitches with tumours than in healthy animals. Significant difference was noticed between malignant tumours and controls (P<0.01). In conclusion, the alterations in antioxidative status occur in bitches with mammary gland tumours, suggests the presence of general antioxidative stress. A necessity of more frequent sample collection for the detection of dynamic changes in peroxidation process revealing the intensity of oxidative stress in bitches suffering from mammary gland tumours should be considered.

Słowa kluczowe

EN

peroxidation process; oxidative stress; veterinary medicine; blood plasma; antioxidant; tumour; mammary gland; animal disease; mammary gland tumour; bitch

• Wydawca: -
• Czasopismo: Bulletin of the Veterinary Institute in Puławy
• Rocznik: 2008
• Tom: 52
• Numer: 2
• Opis fizyczny: p.255-259,ref.

Twórcy

autor

Szczubial M

• University of Life Sciences in Lublin, 20-612 Lublin, Poland

autor

Kankofer M.

autor

Albera E.

autor

Lopuszynski W.

autor

Dabrowski R.

Bibliografia

• 1. Abdi S., Ali A.: Role of ROS modified human DNA in the pathogenesis and etiology of cancer. Cancer Lett 1999, 142, 1-9.
• 2. Afrasyap L., Guvenen G., Turkmen S.: Plasma and erythrocyte total antioxidant status in patients with benign and malignant breast disease. Cancer Biochem Biophys 1998, 16, 129-138.
• 3. Alberti A., Bolognini L., Macciantelli D., Caratelli M.: The radical cation of N,N-diethyl-paraphenylenediamine: a possible indicator of oxidative stress in biological samples. Res Chem Intermed 2000, 26, 253-267.
• 4. Arnesen K., Gamlem H., Glattre E., Moe L., Nordstoga K.: Registration of canine cancer. Tidsskr Nor Laegeforen 1995, 115, 714-717.
• 5. Bałasińska B.: Evaluation of antioxidant status in living organisms. Medycyna Wet 2004, 60, 579-583.
• 6. Benzie I.F., Strain J.J.: The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP assay. Anal Biochem 1996, 239, 70-76.
• 7. Blackburn R.V., Spitz D.R., Liu X., Galoforo S.S., Sim J.E., Ridnour L.A., Chen J.C., Davis B.H., Corry P.M., Lee Y.J.: Metabolic oxidative stress activates signal transduction and gene expression during glucose deprivation in human tumor cells. Free Radic Biol Med 1999, 26, 419-430.
• 8. Cerutti P., Ghosh R., Oya Y. Amstad P.: The role of the cellular defense in oxidant carcinogenesis. Environ Health Perspect 1994, 102, 123-128.
• 9. Ching S., Ingram D., Hahnel R., Beilby J., Rossi E.: Serum levels of micronutrients, antioxidants and total antioxidant status predict risk of breast cancer in case control study. J Nutr 2002, 132, 303-306.
• 10. Dreher D., Junod A.F.: Role of oxygen free radicals in cancer development. Eur J Cancer 1996, 32 A, 30-38.
• 11. Frei B., Stacker R., Ames B.N.: Antioxidant defenses and lipid peroxidation in human blood plasma. Proc Natl Acad Sci USA 1988, 85, 9748-9752.
• 12. Halliwell B.: Oxidants and human disease: some new concepts. Free Radic Biol Med 1988, 5, 237-246.
• 13. Halliwell B.: Antioxidants in human health and disease. Ann Rev Nutr 1996, 16, 33-50.
• 14. Halliwell B., Whiteman M.: Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean? Br J Pharmacol 2004, 142, 231-255.
• 15. Hristozov D., Gadjeva V., Vlaykova T., Dimitrov G.: Evaluation of oxidative stress in patients with cancer. Arch Physiol Biochem 2001, 109, 331-336.
• 16. Kim M.K., Park Y.G., Gong G., Ahn S.H.: Breast cancer, serum antioxidant vitamins, and p53 protein overexpression. Nutr Cancer 2002, 43, 159-166.
• 17. Kolanjiappan K., Manoharan S., Kayalvizhi M.: Measurement of erythrocyte lipids, lipid peroxidation, antioxidants and osmotic fragility in cervical cancer patients. Clin Chim Acta 2002, 326, 143-149.
• 18. Kovacic P., Jacintho J.D.: Mechanism of carcinogenesis: focus on oxidative stress and electron transfer. Curr Med Chem 2001, 8, 773-796.
• 19. Kumaraguruparan R., Subapriya R., Kabalimoorthy J., Nagini S.: Antioxidant profile in the circulation of patients with fibroadenoma and adenocarcinoma of the breast. Clin Biochem 2002, 35, 275-279.
• 20. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J.: Protein measurement with the Folin phenol reagent. J Biol Chem 1951, 193, 265-275.
• 21. Malicka E., Piusiński W., Sendecka H., Bielecki W., Osińska B., Lenartowicz-Kubrat Z.: Neoplasma in dogs on the basis of pathomorphological examinations in the years 1985-1993. Medycyna Wet 1996, 52, 103-106.
• 22. Mantovani G., Maccio A., Lai P., Massa E., Ghiani M., Santona M.C.: Cytokine activity in cancer-related anorexia/cachexia: role of megestrol acetate and medroxyprogesterone acetate. Semin Oncol 1998, 25, 45- 52.
• 23. Marnett L.J., Riggins J.N., West J.D.: Endogenous generation of reactive oxidants and electrophiles and their reactions with DNA and protein. J Clin Invest 2003, 111, 583-593.
• 24. McLellan L., Wolf C.: Glutathione and glutathione- dependent enzymes in cancer drug resistance. Drug Resist Updat 1999, 2, 153-164.
• 25. Misdorp W., Else R., Hellmen E., Lipscomb T.P.: Histological Classification of Mammary Tumors of the Dog and the Cat. In: World Health Organization International. Histological Classification of Tumors of Domestic Animals, edited by Armed Forces Institute of Pathology, Washington, 1999.
• 26. Nowak M., Madej J.A.: Prevalence of neoplasms in domestic animals in Lower Silesia between 2000 and 2004. Medycyna Wet 2006, 62, 900-904.
• 27. Polat M. F., Taysi S., Gul M., Cikman O., Yilmaz I., Bakan E., Erdogan F.: Oxidant/antioxidant status in blood of patients with malignant breast tumour and benign breast disease. Cell Biochem Funct 2002, 20, 327- 331.
• 28. Prior R. L., Cao G.: In vivo total antioxidant capacity: comparison of different analytical methods. Free Radic Biol Med 1999, 27, 1173-1181.
• 29. Saygili E. I., Akcay T., Konukoglu D., Papilla C.: Glutathione and glutathione-related enzymes in colorectal cancer patients. J Toxicol Environ Health A 2003, 66, 411-415.
• 30. Shaughnessy S.G., Buchanan M.R., Turple S., Richardson M., Orr F.W.: Walker carcinosarcoma cells damage endothelial cells by the generation of reactive oxygen species. Am J Pathol 1989, 134, 787-796.
• 31. Sies H., Stahl W.: Vitamins E and C, beta-carotene, and other carotenoids as antioxidants. Am J Clin Nutr 1995, 62, 1315-1321.
• 32. Suzuki I., Katoh N.: A simple and cheap method for measuring serum vitamin A in cattle using only a spectrophotometer. Jpn J Vet Sci 1990, 52, 1281-1283.
• 33. Szczubiał M., Kankofer M., Łopuszyński W., Dąbrowski R., Lipko J.: Oxidative stress parameters in bitches with mammary gland tumours. J Vet Med A 2004, 51, 336- 340.
• 34. Wallace S.S.: Biological consequences of free radical- damaged DNA bases. Free Radic Biol Med 2002, 33, 1- 14.
• 35. Zwart L.L., Meerman J.H., Commandeur J.N., Vermeulen N.P.: Biomarkers of free radical damage applications in experimental animals and in humans. Free Radic Biol Med 1999, 26, 202-226.